Effects of caffeic acid phenethyl ester on isoproterenol-induced myocardial infarction in rats;kafeik asit fenetil esterin siçanlarda isoproterenol indüklü miyokardiyal infarktüs üzerine etkileri

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 4, 2010, Pages 298-302

  Oktar, Süleyman ^a   Aydin, Mehmet ^a   Yönden, Zafer ^a   Alçin, Ergul ^a   Ilhan, Selçuk ^b   Nacar, Ahmet ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Caffeic acid phenethyl ester; Isoproterenol; Lipid peroxidation; Myeloperoxidase; Myocardial infarction; Oxidative stress

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CATALASE; ISOPRENALINE; MALONALDEHYDE; MYELOPEROXIDASE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART INFARCTION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ASPARTATE AMINOTRANSFERASES; CAFFEIC ACIDS; CARDIOTONIC AGENTS; CREATINE KINASE; CYTOTOXINS; FEMALE; FLAVONOIDS; HUMANS; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; MYOCARDIAL INFARCTION; PEROXIDASE; PHENYLETHYL ALCOHOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 77955797773     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.086     Document Type: Article

References (35)

1. Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure. Cardiol Rev 2006; 14: 108-24.
2. De Biase L, Pignatelli P, Lenti L, Tocci G, Piccioni F, Riondino S, et al. Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production. Thromb Haemost 2003; 90: 317-25.
3. Sahna E, Deniz E, Bay-Karabulut A, Burma O. Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity. Clin Exp Hypertens 2008; 30: 673-81.
4. Wexler BC. Myocardial infarction in young vs old male rats: pathophysiologic changes. Am Heart J 1978; 96: 70-80.
5. Zhou B, Wu LJ, Li LH, Tashiro S, Onodera S, Uchiumi F, et al. Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1. J Pharmacol Sci 2006; 102: 387-95.
6. Rajadurai M, Prince PS. Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. Toxicology 2007; 232: 216-25.
7. Tseng TH, Lee YJ. Evaluation of natural and synthetic compounds from East Asiatic folk medicinal plants on the mediation of cancer. Anticancer Agents Med Chem 2006; 6: 347-65.
8. Okutan H, Ozcelik N, Yilmaz HR, Uz E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 2005; 38: 191-6.
9. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329: 21-4.
10. Parlakpinar H, Sahna E, Acet A, Mizrak B, Polat A. Protective effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemiareperfusion-induced apoptotic cell death. Toxicology 2005; 209: 11-4.
11. Fadillioǧlu E, Oztaş E, Erdoǧan H, Yaǧmurca M, Soǧut S, Ucar M, et al. Protective effects of caffeic acid phenethyl ester on doxorubicininduced cardiotoxicity in rats. J Appl Toxicol 2004; 24: 47-52.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
13. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
14. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 1991; 51: 4443-9.
15. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
16. nd English ed. New York: Academic Press; 1974.
17. Senthil S, Sridevi M, Pugalendi KV. Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats. Toxicol Pathol 2007; 35: 418-23.
18. Trivedi CJ, Balaraman R, Majithiya JB, Bothara SB. Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats. Pharmacology 2006; 77: 25-32.
19. Hori M, Fukui S, Nishimoto Y, Inoue M, Abe H. A method for the estimation of peak serum LDH activity based on a single post-peak level after acute myocardial infarction. Jpn Heart J 1977; 18: 202-13.
20. Zembron-Lacny A, Szyszka K, Sobanska B, Pakula R. Prooxidantantioxidant equilibrium in rowers: effect of a single dose of vitamin E. J Sports Med Phys Fitness 2006; 46: 257-64.
21. Demirdaǧ K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A, Kilic SS. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepatogastroenterology 2003; 50: 766-70.
22. Brodde OE. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991; 43: 203-42.
23. Wheatley AM, Thandroyen FT, Opie LH. Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome. J Mol Cell Cardiol 1985; 17: 349-59.
24. Acikel M, Buyukokuroǧlu ME, Aksoy H, Erdoǧan F, Erol MK. Protective effects of melatonin against myocardial injury induced by isoproterenol in rats. J Pineal Res 2003; 35: 75-9.
25. Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative crosslinking of proteins. J Clin Invest 1993; 91: 2866-72.
26. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 1102-11.
27. Tan J, Ma Z, Han L, Du R, Zhao L, Wei X, et al. Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2005; 289: H2265-71.
28. Saavedra-Lopes M, Ramalho FS, Ramalho LN, Andrade-Silva A, Martinelli AL, Jordao AA, et al. The protective effect of CAPE on hepatic ischemia/reperfusion injury in rats. J Surg Res 2008; 150: 271-7.
29. Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2009; 103: 333-7.
30. Saeed SA, Ahmed S. New aspects of cyclooxygenase-2 inhibition in myocardial infarction and ischaemia. Res Commun Mol Pathol Pharmacol 2005; 117-118: 167-78.
31. Asselbergs FW, Tervaert JW, Tio RA. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2004; 350: 516-8.
32. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2136-42.
33. Panda VS, Naik SR. Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol 2008; 60: 397-404.
34. Belboul A, Lofgren C, Storm C, Jungbeck M. Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial. Eur J Cardiothorac Surg 2000; 17: 580-6.
35. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 2001; 225: 75-83.